MedPath

Comparison of Pueraria mirifica Gel and Conjugated Equine Oestrogen Cream Effects on Vaginal Health in Postmenopausal Wome

Phase 3
Recruiting
Conditions
lactobacillus grading
pueraria mirifica
postmenopausal women
vaginal dryness
Vulvovaginal symptom
vaginal cytology
Registration Number
TCTR20150219001
Lead Sponsor
Faculty of Medicine, Ramathibodi Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
82
Inclusion Criteria

A healthy postmenopausal women who
1. aged 40-75 years
2. last menstrual period at least one year before
3. intact uterus
4. have at least one of vulvovaginal symptom; dryness, soreness, irritation, dyspareunia or abnormal discharge
5. no contraindication for hormone therapy
6. no history of breast and any hormonal sensitive cancer

Exclusion Criteria

A women who
1. want to withdraw from the study
2. treatment adherence less than 80%

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vaginal Maturation Index 1st visit, 6-week and 12-week Vaginal cytology for assessing maturation index
Secondary Outcome Measures
NameTimeMethod
Vaginal symptom score 1st visit, 6-week, 12-week Questionaire,Vaginal assessment score 1st visit, 6-week, 12-week Pelvic examination and scored by examiner,Lactobacillus grading 1st visit, 12-week Vaginal smear for Gram stain
© Copyright 2025. All Rights Reserved by MedPath